Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,628.40
+0.60 (0.04%)
Oct 28, 2025, 3:29 PM IST
Eris Lifesciences Employees
Eris Lifesciences had 3,354 employees as of March 31, 2025. The number of employees decreased by 266 or -7.35% compared to the previous year.
Employees
3,354
Change (1Y)
-266
Growth (1Y)
-7.35%
Revenue / Employee
8.75M INR
Profits / Employee
1.15M INR
Market Cap
221.72B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3,354 | -266 | -7.35% |
| Mar 31, 2024 | 3,620 | 939 | 35.02% |
| Mar 31, 2023 | 2,681 | -719 | -21.15% |
| Mar 31, 2022 | 3,400 | 154 | 4.74% |
| Mar 31, 2021 | 3,246 | -184 | -5.36% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Glenmark Pharmaceuticals | 15,800 |
Eris Lifesciences News
- 2 months ago - Eris Lifesciences secures ANVISA approval for Ahmedabad sterile injectable facility - Business Upturn
- 2 months ago - Eris Lifesciences secures approval from ANVISA for Ahmedabad facility - Business Upturn
- 2 months ago - Eris Lifesciences shares plunge nearly 5% today despite 41% jump in Q1 net profit - Business Upturn
- 3 months ago - Eris Lifesciences Q1 Results: Net profit jump 41.7% YoY to Rs 118 crore, revenue up 7.8% YoY - Business Upturn
- 5 months ago - Eris Lifesciences shares jump 3% as Q4 EBITDA rises 69.8% YoY to 252.2 crore - Business Upturn
- 6 months ago - Eris Lifesciences, Lupin and Biocon shares in focus as Novo Nordisk exits Rs 800 crore Human Mixtard brand, says report - Business Upturn
- 6 months ago - Eris Lifesciences shares surge over 4% as Novo Nordisk reportedly exits Human Mixtard insulin market in India - Business Upturn
- 9 months ago - Eris Lifesciences shares drop 4% as net profit dips 14.3% YoY in Q3 - Business Upturn